ABLE C Competent Cells by Agilent Technologies

Manufacturer Agilent Technologies  |   Model: 200171
The ABLE C strain and the ABLE K strain help solve issues associated with toxic clones. The ABLE C strain reduces the copy number of ColE1-derived plasmids, e.g. pUC and pBluescript, by approximately 4-fold (compared to the XL1-Blue strain) and the ABLE K strain reduces the copy number of these plasmids approximately 10-fold. 


ABLE C Competent Cells by Agilent Technologies product image
ABLE C Competent Cells
Request Pricing

Receive your quote directly from the manufacturer.



0 Scientists have reviewed this product


Write the First Review

No Reviews

The ABLE C strain and the ABLE K strain help solve issues associated with toxic clones. The ABLE C strain reduces the copy number of ColE1-derived plasmids, e.g. pUC and pBluescript, by approximately 4-fold (compared to the XL1-Blue strain) and the ABLE K strain reduces the copy number of these plasmids approximately 10-fold. This decreases the level of cloned protein product, increasing cell viability when proteins are toxic to the cells.

  • F’ episome allows M13 infection
  • Available as chemically and electroporation-competent cells
     

For Research Use Only. Not for Use in Diagnostic Procedures.